Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study
Human papillomavirus (HPV), the causal agent of cervical cancer, appears to be involved in the etiology of cancer of the oral cavity and oropharynx. To investigate these associations, we conducted a multicenter case-control study of cancer of the oral cavity and oropharynx in nine countries. We recr...
Saved in:
| Published in | JNCI : Journal of the National Cancer Institute Vol. 95; no. 23; pp. 1772 - 1783 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
Cary, NC
Oxford University Press
03.12.2003
Oxford Publishing Limited (England) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1460-2105 0027-8874 1460-2105 |
| DOI | 10.1093/jnci/djg107 |
Cover
| Abstract | Human papillomavirus (HPV), the causal agent of cervical cancer, appears to be involved in the etiology of cancer of the oral cavity and oropharynx. To investigate these associations, we conducted a multicenter case-control study of cancer of the oral cavity and oropharynx in nine countries.
We recruited 1670 case patients (1415 with cancer of the oral cavity and 255 with cancer of the oropharynx) and 1732 control subjects and obtained an interview, oral exfoliated cells, and blood from all participants and fresh biopsy specimens from case patients. HPV DNA was detected by polymerase chain reaction (PCR). Antibodies against HPV16 L1, E6, and E7 proteins in plasma were detected with enzyme-linked immunosorbent assays. Multivariable models were used for case-control and case-case comparisons.
HPV DNA was detected in biopsy specimens of 3.9% (95% confidence interval [CI] = 2.5% to 5.3%) of 766 cancers of the oral cavity with valid PCR results and 18.3% (95% CI = 12.0% to 24.7%) of 142 cancers of the oropharynx (oropharynx and tonsil combined) with valid PCR results. HPV DNA in cancer biopsy specimens was detected less frequently among tobacco smokers and paan chewers and more frequently among subjects who reported more than one sexual partner or who practiced oral sex. HPV16 DNA was found in 94.7% of HPV DNA-positive case patients. HPV DNA in exfoliated cells was not associated with cancer risk or with HPV DNA detection in biopsy specimens. Antibodies against HPV16 L1 were associated with risk for cancers of the oral cavity (odds ratio [OR] = 1.5, 95% CI = 1.1 to 2.1) and the oropharynx (OR = 3.5, 95% CI = 2.1 to 5.9). Antibodies against HPV16 E6 or E7 were also associated with risk for cancers of the oral cavity (OR = 2.9, 95% CI = 1.7 to 4.8) and the oropharynx (OR = 9.2, 95% CI = 4.8 to 17.7).
HPV appears to play an etiologic role in many cancers of the oropharynx and possibly a small subgroup of cancers of the oral cavity. The most common HPV type in genital cancers (HPV16) was also the most common in these tumors. The mechanism of transmission of HPV to the oral cavity warrants further investigation. |
|---|---|
| AbstractList | Human papillomavirus (HPV), the causal agent of cervical cancer, appears to be involved in the etiology of cancer of the oral cavity and oropharynx. To investigate these associations, we conducted a multicenter case-control study of cancer of the oral cavity and oropharynx in nine countries.BACKGROUNDHuman papillomavirus (HPV), the causal agent of cervical cancer, appears to be involved in the etiology of cancer of the oral cavity and oropharynx. To investigate these associations, we conducted a multicenter case-control study of cancer of the oral cavity and oropharynx in nine countries.We recruited 1670 case patients (1415 with cancer of the oral cavity and 255 with cancer of the oropharynx) and 1732 control subjects and obtained an interview, oral exfoliated cells, and blood from all participants and fresh biopsy specimens from case patients. HPV DNA was detected by polymerase chain reaction (PCR). Antibodies against HPV16 L1, E6, and E7 proteins in plasma were detected with enzyme-linked immunosorbent assays. Multivariable models were used for case-control and case-case comparisons.METHODSWe recruited 1670 case patients (1415 with cancer of the oral cavity and 255 with cancer of the oropharynx) and 1732 control subjects and obtained an interview, oral exfoliated cells, and blood from all participants and fresh biopsy specimens from case patients. HPV DNA was detected by polymerase chain reaction (PCR). Antibodies against HPV16 L1, E6, and E7 proteins in plasma were detected with enzyme-linked immunosorbent assays. Multivariable models were used for case-control and case-case comparisons.HPV DNA was detected in biopsy specimens of 3.9% (95% confidence interval [CI] = 2.5% to 5.3%) of 766 cancers of the oral cavity with valid PCR results and 18.3% (95% CI = 12.0% to 24.7%) of 142 cancers of the oropharynx (oropharynx and tonsil combined) with valid PCR results. HPV DNA in cancer biopsy specimens was detected less frequently among tobacco smokers and paan chewers and more frequently among subjects who reported more than one sexual partner or who practiced oral sex. HPV16 DNA was found in 94.7% of HPV DNA-positive case patients. HPV DNA in exfoliated cells was not associated with cancer risk or with HPV DNA detection in biopsy specimens. Antibodies against HPV16 L1 were associated with risk for cancers of the oral cavity (odds ratio [OR] = 1.5, 95% CI = 1.1 to 2.1) and the oropharynx (OR = 3.5, 95% CI = 2.1 to 5.9). Antibodies against HPV16 E6 or E7 were also associated with risk for cancers of the oral cavity (OR = 2.9, 95% CI = 1.7 to 4.8) and the oropharynx (OR = 9.2, 95% CI = 4.8 to 17.7).RESULTSHPV DNA was detected in biopsy specimens of 3.9% (95% confidence interval [CI] = 2.5% to 5.3%) of 766 cancers of the oral cavity with valid PCR results and 18.3% (95% CI = 12.0% to 24.7%) of 142 cancers of the oropharynx (oropharynx and tonsil combined) with valid PCR results. HPV DNA in cancer biopsy specimens was detected less frequently among tobacco smokers and paan chewers and more frequently among subjects who reported more than one sexual partner or who practiced oral sex. HPV16 DNA was found in 94.7% of HPV DNA-positive case patients. HPV DNA in exfoliated cells was not associated with cancer risk or with HPV DNA detection in biopsy specimens. Antibodies against HPV16 L1 were associated with risk for cancers of the oral cavity (odds ratio [OR] = 1.5, 95% CI = 1.1 to 2.1) and the oropharynx (OR = 3.5, 95% CI = 2.1 to 5.9). Antibodies against HPV16 E6 or E7 were also associated with risk for cancers of the oral cavity (OR = 2.9, 95% CI = 1.7 to 4.8) and the oropharynx (OR = 9.2, 95% CI = 4.8 to 17.7).HPV appears to play an etiologic role in many cancers of the oropharynx and possibly a small subgroup of cancers of the oral cavity. The most common HPV type in genital cancers (HPV16) was also the most common in these tumors. The mechanism of transmission of HPV to the oral cavity warrants further investigation.CONCLUSIONSHPV appears to play an etiologic role in many cancers of the oropharynx and possibly a small subgroup of cancers of the oral cavity. The most common HPV type in genital cancers (HPV16) was also the most common in these tumors. The mechanism of transmission of HPV to the oral cavity warrants further investigation. BACKGROUND: Human papillomavirus (HPV), the causal agent of cervical cancer, appears to be involved in the etiology of cancer of the oral cavity and oropharynx. To investigate these associations, we conducted a multicenter case-control study of cancer of the oral cavity and oropharynx in nine countries. METHODS: We recruited 1670 case patients (1415 with cancer of the oral cavity and 255 with cancer of the oropharynx) and 1732 control subjects and obtained an interview, oral exfoliated cells, and blood from all participants and fresh biopsy specimens from case patients. HPV DNA was detected by polymerase chain reaction (PCR). Antibodies against HPV16 L1, E6, and E7 proteins in plasma were detected with enzyme-linked immunosorbent assays. Multivariable models were used for case-control and case-case comparisons. RESULTS: HPV DNA was detected in biopsy specimens of 3.9% (95% confidence interval [CI] = 2.5% to 5.3%) of 766 cancers of the oral cavity with valid PCR results and 18.3% (95% CI = 12.0% to 24.7%) of 142 cancers of the oropharynx (oropharynx and tonsil combined) with valid PCR results. HPV DNA in cancer biopsy specimens was detected less frequently among tobacco smokers and paan chewers and more frequently among subjects who reported more than one sexual partner or who practiced oral sex. HPV16 DNA was found in 94.7% of HPV DNA-positive case patients. HPV DNA in exfoliated cells was not associated with cancer risk or with HPV DNA detection in biopsy specimens. Antibodies against HPV16 L1 were associated with risk for cancers of the oral cavity (odds ratio [OR] = 1.5, 95% CI = 1.1 to 2.1) and the oropharynx (OR = 3.5, 95% CI = 2.1 to 5.9). Antibodies against HPV16 E6 or E7 were also associated with risk for cancers of the oral cavity (OR = 2.9, 95% CI = 1.7 to 4.8) and the oropharynx (OR = 9.2, 95% CI = 4.8 to 17.7). CONCLUSIONS: HPV appears to play an etiologic role in many cancers of the oropharynx and possibly a small subgroup of cancers of the oral cavity. The most common HPV type in genital cancers (HPV16) was also the most common in these tumors. The mechanism of transmission of HPV to the oral cavity warrants further investigation. Human papillomavirus (HPV), the causal agent of cervical cancer, appears to be involved in the etiology of cancer of the oral cavity and oropharynx. To investigate these associations, we conducted a multicenter case-control study of cancer of the oral cavity and oropharynx in nine countries. We recruited 1670 case patients (1415 with cancer of the oral cavity and 255 with cancer of the oropharynx) and 1732 control subjects and obtained an interview, oral exfoliated cells, and blood from all participants and fresh biopsy specimens from case patients. HPV DNA was detected by polymerase chain reaction (PCR). Antibodies against HPV16 L1, E6, and E7 proteins in plasma were detected with enzyme-linked immunosorbent assays. Multivariable models were used for case-control and case-case comparisons. HPV DNA was detected in biopsy specimens of 3.9% (95% confidence interval [CI] = 2.5% to 5.3%) of 766 cancers of the oral cavity with valid PCR results and 18.3% (95% CI = 12.0% to 24.7%) of 142 cancers of the oropharynx (oropharynx and tonsil combined) with valid PCR results. HPV DNA in cancer biopsy specimens was detected less frequently among tobacco smokers and paan chewers and more frequently among subjects who reported more than one sexual partner or who practiced oral sex. HPV16 DNA was found in 94.7% of HPV DNA-positive case patients. HPV DNA in exfoliated cells was not associated with cancer risk or with HPV DNA detection in biopsy specimens. Antibodies against HPV16 L1 were associated with risk for cancers of the oral cavity (odds ratio [OR] = 1.5, 95% CI = 1.1 to 2.1) and the oropharynx (OR = 3.5, 95% CI = 2.1 to 5.9). Antibodies against HPV16 E6 or E7 were also associated with risk for cancers of the oral cavity (OR = 2.9, 95% CI = 1.7 to 4.8) and the oropharynx (OR = 9.2, 95% CI = 4.8 to 17.7). HPV appears to play an etiologic role in many cancers of the oropharynx and possibly a small subgroup of cancers of the oral cavity. The most common HPV type in genital cancers (HPV16) was also the most common in these tumors. The mechanism of transmission of HPV to the oral cavity warrants further investigation. Human papillomavirus (HPV), the causal agent of cervical cancer, appears to be involved in the etiology of cancer of the oral cavity and oropharynx. To investigate these associations, we conducted a multicenter case-control study of cancer of the oral cavity and oropharynx in nine countries. We recruited 1670 case patients (1415 with cancer of the oral cavity and 255 with cancer of the oropharynx) and 1732 control subjects and obtained an interview, oral exfoliated cells, and blood from all participants and fresh biopsy specimens from case patients. HPV DNA was detected by polymerase chain reaction (PCR). Antibodies against HPV16 L1, E6, and E7 proteins in plasma were detected with enzyme-linked immunosorbent assays. Multivariable models were used for case-control and case-case comparisons. HPV DNA was detected in biopsy specimens of 3.9% (95% confidence interval [CI] = 2.5% to 5.3%) of 766 cancers of the oral cavity with valid PCR results and 18.3% (95% CI = 12.0% to 24.7%) of 142 cancers of the oropharynx (oropharynx and tonsil combined) with valid PCR results. HPV DNA in cancer biopsy specimens was detected less frequently among tobacco smokers and paan chewers and more frequently among subjects who reported more than one sexual partner or who practiced oral sex. HPV16 DNA was found in 94.7% of HPV DNA-positive case patients. HPV DNA in exfoliated cells was not associated with cancer risk or with HPV DNA detection in biopsy specimens. Antibodies against HPV16 L1 were associated with risk for cancers of the oral cavity (odds ratio [OR] = 1.5, 95% CI = 1.1 to 2.1) and the oropharynx (OR = 3.5, 95% CI = 2.1 to 5.9). Antibodies against HPV16 E6 or E7 were also associated with risk for cancers of the oral cavity (OR = 2.9, 95% CI = 1.7 to 4.8) and the oropharynx (OR = 9.2, 95% CI = 4.8 to 17.7). HPV appears to play an etiologic role in many cancers of the oropharynx and possibly a small subgroup of cancers of the oral cavity. The most common HPV type in genital cancers (HPV16) was also the most common in these tumors. The mechanism of transmission of HPV to the oral cavity warrants further investigation. |
| Author | Herrero, R. |
| Author_xml | – sequence: 1 givenname: R. surname: Herrero fullname: Herrero, R. |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15927572$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/14652239$$D View this record in MEDLINE/PubMed |
| BookMark | eNqF0c1vFCEYBnBiauyHnrwbYqIXsxYY2AFvzUZtkzY1Ws_khWG2bBjYwozJ_vey7rY2jYlcIHl_D4fnPUYHMUWH0GtKPlKimtNVtP60Wy0paZ-hI8rnZMYoEQeP3ofouJQVqUcx_gId1oFgrFFHaHk-DRDxN1j7ENIAv3yeCobY4esMAS8gWpc_4Ztbhy_i6HKE0adYJ2dLF-0G9ynj7644yPYWp7gP4KspjN66bQL_GKdu8xI97yEU92p_n6CfXz7fLM5nl9dfLxZnlzPbKNrO-lY1hBMzN0YQIq1Q0PJ511kinDRGMsu5bLhRHTgpgINtJJurzgBY2hvbnKD3u3_XOd1Nrox68MW6ECC6NBXdUs6kYOq_kCpGJRO8wrdP4CpNtYdQNGNESdpKWdGbPZrM4Dq9zn6AvNH3RVfwbg-gWAh9rj358tcJxVrRsuroztmcSsmu19aPfzofM_igKdHbpevt0vVu6TXz4Unm4dt_6N9jBa5k |
| CODEN | JNCIEQ |
| CitedBy_id | crossref_primary_10_1111_j_1601_0825_2012_01950_x crossref_primary_10_1186_1471_2407_13_26 crossref_primary_10_1093_annonc_mdx304 crossref_primary_10_1186_1750_9378_6_4 crossref_primary_10_1002_cam4_424 crossref_primary_10_1038_s41368_019_0069_7 crossref_primary_10_1093_annonc_mdn643 crossref_primary_10_1007_s10552_014_0490_3 crossref_primary_10_1158_1055_9965_EPI_14_0282 crossref_primary_10_1016_S1201_9712_07_60015_0 crossref_primary_10_47102_annals_acadmedsg_V39N12p897 crossref_primary_10_1093_epirev_mxw001 crossref_primary_10_1016_j_canep_2015_10_015 crossref_primary_10_1007_s00405_013_2693_8 crossref_primary_10_1038_sj_cgt_7700926 crossref_primary_10_1111_jebm_12159 crossref_primary_10_1586_14737140_2015_957189 crossref_primary_10_1007_s00432_017_2528_x crossref_primary_10_1016_j_oraloncology_2006_11_010 crossref_primary_10_7314_APJCP_2012_13_3_891 crossref_primary_10_1002_cncr_33221 crossref_primary_10_5005_jp_journals_10024_2791 crossref_primary_10_1111_adj_12020 crossref_primary_10_1016_j_ctrv_2015_10_009 crossref_primary_10_3390_v13040559 crossref_primary_10_1002_ijc_28665 crossref_primary_10_1016_j_clon_2011_05_007 crossref_primary_10_1186_s40463_015_0082_6 crossref_primary_10_1016_j_jinf_2013_03_005 crossref_primary_10_1590_S1413_81232010000700018 crossref_primary_10_1002_lary_26972 crossref_primary_10_1007_s11864_006_0027_4 crossref_primary_10_1017_S0022215107006482 crossref_primary_10_1007_s12070_023_04174_6 crossref_primary_10_1002_prca_201400091 crossref_primary_10_1002_ijc_20940 crossref_primary_10_1071_SH10006 crossref_primary_10_1016_j_oraloncology_2017_03_013 crossref_primary_10_1016_j_otc_2012_04_003 crossref_primary_10_1051_mbcb_2012042 crossref_primary_10_3322_caac_21167 crossref_primary_10_1186_1746_160X_6_15 crossref_primary_10_1308_204268510X12804095837951 crossref_primary_10_1002_ijc_30516 crossref_primary_10_1016_j_ejca_2004_11_023 crossref_primary_10_1007_s11904_008_0020_6 crossref_primary_10_1002_hed_20663 crossref_primary_10_1002_jmv_23750 crossref_primary_10_1200_JCO_2016_68_2955 crossref_primary_10_1038_bjc_2011_171 crossref_primary_10_1186_1750_9378_4_16 crossref_primary_10_1093_jnci_djh183 crossref_primary_10_1002_ijc_28201 crossref_primary_10_1186_s12885_020_07427_7 crossref_primary_10_1111_odi_12071 crossref_primary_10_1186_1750_9378_6_9 crossref_primary_10_1097_MLG_0b013e31813e5fbb crossref_primary_10_1007_s00405_018_4954_z crossref_primary_10_1002_rmv_714 crossref_primary_10_1016_j_ijscr_2020_09_064 crossref_primary_10_1016_j_oraloncology_2008_06_002 crossref_primary_10_1002_ijc_32713 crossref_primary_10_1111_j_1751_1097_2007_00266_x crossref_primary_10_1016_j_critrevonc_2021_103424 crossref_primary_10_1002_cncr_24309 crossref_primary_10_1155_2015_791024 crossref_primary_10_1017_S002221511900224X crossref_primary_10_4103_ijc_IJC_599_19 crossref_primary_10_1097_01_OLQ_0000430798_61475_08 crossref_primary_10_1016_j_oraloncology_2011_07_004 crossref_primary_10_3892_br_2024_1870 crossref_primary_10_1002_jmv_24614 crossref_primary_10_1016_j_canep_2009_05_003 crossref_primary_10_2217_14796694_2_1_1 crossref_primary_10_1016_j_oraloncology_2016_07_006 crossref_primary_10_1371_journal_pone_0062066 crossref_primary_10_1016_S1674_8301_10_60047_4 crossref_primary_10_9778_cmajo_20140005 crossref_primary_10_3390_venereology2040016 crossref_primary_10_1093_jnci_djr499 crossref_primary_10_18632_oncotarget_11085 crossref_primary_10_1371_journal_pone_0164491 crossref_primary_10_1097_01_aids_0000226963_10342_f4 crossref_primary_10_1371_journal_pone_0032657 crossref_primary_10_1007_s11912_022_01263_7 crossref_primary_10_29413_ABS_2021_6_5_15 crossref_primary_10_1093_qjmed_hcp176 crossref_primary_10_3892_ijo_2016_3501 crossref_primary_10_3923_jas_2010_981_985 crossref_primary_10_1016_j_yexmp_2012_04_016 crossref_primary_10_3389_fphar_2019_00150 crossref_primary_10_1002_ijc_34919 crossref_primary_10_1371_journal_pone_0123716 crossref_primary_10_1007_s10552_014_0348_8 crossref_primary_10_1155_2009_837514 crossref_primary_10_1515_CCLM_2007_127 crossref_primary_10_1002_hed_20460 crossref_primary_10_1002_hed_23739 crossref_primary_10_1016_j_canep_2020_101840 crossref_primary_10_1158_1078_0432_CCR_11_1944 crossref_primary_10_1002_cncr_26718 crossref_primary_10_1016_j_canep_2021_101925 crossref_primary_10_1007_s12144_018_9807_9 crossref_primary_10_1371_journal_pone_0056622 crossref_primary_10_1016_j_ijrobp_2010_06_028 crossref_primary_10_1158_1055_9965_EPI_17_0170 crossref_primary_10_1093_carcin_bgn039 crossref_primary_10_1093_jnci_djv403 crossref_primary_10_1007_s00106_013_2676_5 crossref_primary_10_1158_1055_9965_EPI_08_0951 crossref_primary_10_1016_j_mehy_2004_03_013 crossref_primary_10_1111_j_1600_0528_2007_00299_x crossref_primary_10_1186_1758_3284_1_22 crossref_primary_10_1016_j_scitotenv_2010_09_010 crossref_primary_10_1016_j_vaccine_2011_02_091 crossref_primary_10_1136_postgradmedj_2016_134603 crossref_primary_10_1007_s12156_010_0051_2 crossref_primary_10_1016_j_jcv_2016_10_011 crossref_primary_10_1371_journal_pgen_1001333 crossref_primary_10_7314_APJCP_2012_13_12_6083 crossref_primary_10_1016_j_oooo_2024_10_082 crossref_primary_10_1186_1750_9378_2_6 crossref_primary_10_1002_hed_27230 crossref_primary_10_1016_j_ypmed_2008_12_022 crossref_primary_10_4132_jptm_2019_05_12 crossref_primary_10_35366_109560 crossref_primary_10_3390_cancers12010253 crossref_primary_10_1016_j_ajoms_2013_01_001 crossref_primary_10_7314_APJCP_2014_15_14_5861 crossref_primary_10_1007_s10552_010_9567_9 crossref_primary_10_1016_j_oraloncology_2014_06_011 crossref_primary_10_1016_j_oraloncology_2003_11_011 crossref_primary_10_1007_s10552_010_9641_3 crossref_primary_10_1186_1750_9378_6_18 crossref_primary_10_1093_annonc_mdt574 crossref_primary_10_3892_ijo_2022_5453 crossref_primary_10_1002_cam4_2039 crossref_primary_10_1556_650_2023_32871 crossref_primary_10_1016_S0246_0351_12_41900_6 crossref_primary_10_1016_j_buildenv_2024_111458 crossref_primary_10_3390_cells8070726 crossref_primary_10_1200_JCO_2006_06_1291 crossref_primary_10_1016_j_oooo_2013_01_020 crossref_primary_10_1200_JCO_2016_69_1667 crossref_primary_10_3390_s120405159 crossref_primary_10_3342_kjorl_hns_2012_55_2_71 crossref_primary_10_1111_odi_12218 crossref_primary_10_1136_bmjopen_2024_088016 crossref_primary_10_1007_s10555_005_5044_4 crossref_primary_10_1016_j_oraloncology_2014_11_011 crossref_primary_10_1097_MOO_0000000000000030 crossref_primary_10_1111_j_1600_0714_2008_00690_x crossref_primary_10_5694_j_1326_5377_2004_tb06362_x crossref_primary_10_1007_s12032_017_1010_6 crossref_primary_10_1177_0145561320934920 crossref_primary_10_1007_s00430_017_0502_5 crossref_primary_10_1517_17530059_2_1_11 crossref_primary_10_1155_2009_412908 crossref_primary_10_1177_0194599811400385 crossref_primary_10_1016_j_coms_2012_01_003 crossref_primary_10_1128_mSphere_00176_18 crossref_primary_10_1128_JCM_43_3_1408_1410_2005 crossref_primary_10_1067_j_cpsurg_2008_10_003 crossref_primary_10_47493_abantmedj_977792 crossref_primary_10_1016_j_oraloncology_2020_104736 crossref_primary_10_1002_ijc_22980 crossref_primary_10_1007_s11912_008_0027_6 crossref_primary_10_1093_jnci_djm233 crossref_primary_10_1016_j_oraloncology_2012_03_002 crossref_primary_10_1111_idh_12295 crossref_primary_10_1371_journal_pone_0069736 crossref_primary_10_1016_j_archoralbio_2013_09_010 crossref_primary_10_7759_cureus_40421 crossref_primary_10_1080_19424396_2021_12222696 crossref_primary_10_1371_journal_pone_0088240 crossref_primary_10_3892_ijo_2016_3563 crossref_primary_10_1111_odi_13322 crossref_primary_10_1007_s00715_012_0154_4 crossref_primary_10_1186_s12967_023_04221_4 crossref_primary_10_1016_j_oraloncology_2019_05_006 crossref_primary_10_1371_journal_pone_0170091 crossref_primary_10_1158_1055_9965_EPI_14_0084 crossref_primary_10_1097_01_moo_0000170524_74264_b1 crossref_primary_10_1155_2013_642496 crossref_primary_10_1634_theoncologist_2012_0200 crossref_primary_10_4103_SDJ_SDJ_73_21 crossref_primary_10_1371_journal_pone_0035522 crossref_primary_10_1158_1055_9965_EPI_08_0347 crossref_primary_10_1002_ijc_23848 crossref_primary_10_1097_MRM_0000000000000279 crossref_primary_10_1016_j_ejca_2009_08_018 crossref_primary_10_1093_carcin_bgx106 crossref_primary_10_3390_pathogens11040476 crossref_primary_10_1002_cam4_3327 crossref_primary_10_1111_j_1600_0757_2011_00387_x crossref_primary_10_1186_s40902_018_0156_2 crossref_primary_10_1002_hed_21500 crossref_primary_10_1007_s12105_008_0066_1 crossref_primary_10_1111_jop_12770 crossref_primary_10_2217_fvl_14_44 crossref_primary_10_1186_1472_6831_12_43 crossref_primary_10_1111_odi_12251 crossref_primary_10_1016_j_jviromet_2012_09_002 crossref_primary_10_1016_j_femsre_2005_01_005 crossref_primary_10_1073_pnas_0406904102 crossref_primary_10_1016_j_oraloncology_2017_02_019 crossref_primary_10_2217_fon_2020_0931 crossref_primary_10_1158_1055_9965_EPI_08_0560 crossref_primary_10_1093_jnci_djt053 crossref_primary_10_2105_AJPH_2013_301764 crossref_primary_10_1111_odi_12269 crossref_primary_10_3390_biomedicines8040081 crossref_primary_10_1002_ijc_21210 crossref_primary_10_1016_j_oraloncology_2008_05_013 crossref_primary_10_1080_20786204_2010_10874050 crossref_primary_10_1007_s00106_008_1867_y crossref_primary_10_1016_j_canep_2015_10_006 crossref_primary_10_17650_2222_1468_2018_8_3_77_83 crossref_primary_10_1016_j_microc_2024_111741 crossref_primary_10_1016_j_ejca_2012_03_014 crossref_primary_10_1016_S1470_2045_12_70395_9 crossref_primary_10_1093_jnci_dji072 crossref_primary_10_1038_s41598_018_29428_0 crossref_primary_10_1002_ijc_21216 crossref_primary_10_1016_j_canep_2017_02_011 crossref_primary_10_1038_s44328_024_00001_2 crossref_primary_10_1093_carcin_bgt336 crossref_primary_10_1155_2012_575242 crossref_primary_10_1186_s13046_019_1320_y crossref_primary_10_1371_journal_pone_0036888 crossref_primary_10_4103_jofs_jofs_38_21 crossref_primary_10_1177_0194599817691462 crossref_primary_10_3402_acmo_v2_25717 crossref_primary_10_3945_ajcn_113_073163 crossref_primary_10_1002_cncr_31841 crossref_primary_10_1016_j_vaccine_2008_07_056 crossref_primary_10_1080_00313020701230823 crossref_primary_10_1016_j_vaccine_2008_06_021 crossref_primary_10_1155_2020_2474235 crossref_primary_10_1002_ijc_22563 crossref_primary_10_1038_nrc2982 crossref_primary_10_1097_OLQ_0b013e31825d5cb8 crossref_primary_10_2217_FMB_15_55 crossref_primary_10_1186_s12879_015_1067_9 crossref_primary_10_1001_jamaoto_2019_4811 crossref_primary_10_1093_infdis_jiy715 crossref_primary_10_1007_s13193_018_0813_z crossref_primary_10_1051_shsconf_20196802013 crossref_primary_10_3389_fonc_2018_00673 crossref_primary_10_1186_s12920_015_0114_0 crossref_primary_10_1016_j_oooo_2014_08_005 crossref_primary_10_1038_modpathol_2013_70 crossref_primary_10_7314_APJCP_2013_14_10_5567 crossref_primary_10_1146_annurev_publhealth_26_021304_144402 crossref_primary_10_4103_aort_aort_9_21 crossref_primary_10_1038_ncponc0984 crossref_primary_10_1093_annonc_mdp380 crossref_primary_10_1093_annonc_mdq454 crossref_primary_10_1002_ijc_22330 crossref_primary_10_14777_uti_2020_15_3_63 crossref_primary_10_1016_j_oooo_2018_01_003 crossref_primary_10_1158_1078_0432_CCR_09_2877 crossref_primary_10_1002_hed_21197 crossref_primary_10_1038_s41467_024_45074_9 crossref_primary_10_1002_ijc_23430 crossref_primary_10_4236_aim_2014_410073 crossref_primary_10_1016_j_stomax_2011_03_007 crossref_primary_10_1016_j_tripleo_2007_07_007 crossref_primary_10_1016_j_anndiagpath_2008_12_003 crossref_primary_10_1002_jso_21023 crossref_primary_10_1157_13094258 crossref_primary_10_1158_1078_0432_CCR_11_0388 crossref_primary_10_1158_0008_5472_CAN_13_3548 crossref_primary_10_1200_JCO_2010_31_7883 crossref_primary_10_3892_ijo_2017_4071 crossref_primary_10_1016_j_archoralbio_2011_01_010 crossref_primary_10_4103_ijmr_IJMR_2023_17 crossref_primary_10_1007_s12105_007_0021_6 crossref_primary_10_5005_jp_journals_10015_2261 crossref_primary_10_1186_s40001_022_00835_4 crossref_primary_10_1016_j_oraloncology_2013_07_010 crossref_primary_10_3390_ijms19092664 crossref_primary_10_7759_cureus_70752 crossref_primary_10_1158_0008_5472_CAN_11_3277 crossref_primary_10_1097_LGT_0000000000000313 crossref_primary_10_1002_cncr_20998 crossref_primary_10_1038_sj_bdj_2010_345 crossref_primary_10_1016_j_jcv_2015_07_307 crossref_primary_10_1007_s12105_012_0368_1 crossref_primary_10_1016_j_diagmicrobio_2024_116440 crossref_primary_10_1590_S0034_72992006000200021 crossref_primary_10_1016_j_oraloncology_2013_07_013 crossref_primary_10_1038_sj_onc_1209275 crossref_primary_10_1177_09564624231165078 crossref_primary_10_1158_1078_0432_CCR_05_0587 crossref_primary_10_1016_j_jcv_2004_11_017 crossref_primary_10_1056_NEJMoa065497 crossref_primary_10_1586_14737140_8_5_799 crossref_primary_10_1002_ijc_34115 crossref_primary_10_1016_j_jadohealth_2008_07_002 crossref_primary_10_1177_0194599813477992 crossref_primary_10_1111_pin_12461 crossref_primary_10_1007_s00103_018_2791_2 crossref_primary_10_1111_j_1399_302X_2009_00516_x crossref_primary_10_1007_s11248_009_9243_6 crossref_primary_10_1155_2011_509036 crossref_primary_10_1002_dc_23278 crossref_primary_10_1111_j_1600_0714_2012_01178_x crossref_primary_10_1111_j_1365_2559_2010_03576_x crossref_primary_10_1371_journal_pone_0140700 crossref_primary_10_1002_ijc_26500 crossref_primary_10_11606_S1518_8787_2018052000251 crossref_primary_10_3389_fimmu_2018_00745 crossref_primary_10_17795_ijcp_3998 crossref_primary_10_1515_hsz_2017_0105 crossref_primary_10_1016_j_oraloncology_2011_03_017 crossref_primary_10_1016_j_canrad_2018_07_125 crossref_primary_10_1155_2012_521215 crossref_primary_10_1186_1471_2407_7_187 crossref_primary_10_1371_journal_pone_0300354 crossref_primary_10_1093_carcin_bgn191 crossref_primary_10_3390_ijerph192416680 crossref_primary_10_1111_j_1749_4486_2006_01246_x crossref_primary_10_1016_j_oraloncology_2016_06_006 crossref_primary_10_1016_j_soc_2016_07_010 crossref_primary_10_3164_jcbn_39_103 crossref_primary_10_1111_j_1600_0528_2012_00710_x crossref_primary_10_1186_1471_2407_12_159 crossref_primary_10_1016_j_ijid_2018_02_003 crossref_primary_10_17650_2222_1468_2019_9_2_43_52 crossref_primary_10_1017_S0022215121002723 crossref_primary_10_1016_S0716_8640_11_70449_7 crossref_primary_10_1002_ijc_23252 crossref_primary_10_1016_j_cdp_2006_02_001 crossref_primary_10_1016_j_ogc_2013_02_006 crossref_primary_10_1007_s12105_012_0377_0 crossref_primary_10_7314_APJCP_2013_14_7_4335 crossref_primary_10_1111_j_1753_6405_2012_00860_x crossref_primary_10_1016_j_hoc_2008_08_007 crossref_primary_10_1039_C7AY01913K crossref_primary_10_1016_j_hoc_2008_08_006 crossref_primary_10_1016_j_oraloncology_2016_03_012 crossref_primary_10_1002_ijc_22177 crossref_primary_10_3390_cancers13123010 crossref_primary_10_1586_14737140_6_9_1179 crossref_primary_10_1158_0008_5472_CAN_05_3066 crossref_primary_10_1158_0008_5472_CAN_11_2833 crossref_primary_10_1007_s00405_012_2086_4 crossref_primary_10_1016_j_oraloncology_2014_02_011 crossref_primary_10_4132_KoreanJPathol_2010_44_5_483 crossref_primary_10_1158_1055_9965_EPI_09_0334 crossref_primary_10_1371_journal_pone_0040767 crossref_primary_10_1186_s41199_020_00057_3 crossref_primary_10_1186_1758_3284_1_6 crossref_primary_10_1002_mc_23116 crossref_primary_10_1016_j_oraloncology_2011_04_022 crossref_primary_10_1186_1758_3284_1_8 crossref_primary_10_1111_cdoe_12255 crossref_primary_10_1155_2014_804738 crossref_primary_10_1002_ijc_25699 crossref_primary_10_1007_s10354_010_0782_5 crossref_primary_10_1016_j_oraloncology_2020_105136 crossref_primary_10_1007_s00405_011_1714_8 crossref_primary_10_1111_j_1600_0714_2009_00804_x crossref_primary_10_5937_asn1979936A crossref_primary_10_1177_000348940911800509 crossref_primary_10_1016_j_bjorl_2015_04_001 crossref_primary_10_1002_hed_25724 crossref_primary_10_1097_OLQ_0000000000000264 crossref_primary_10_1186_1916_0216_42_23 crossref_primary_10_1016_j_ejogrb_2005_09_009 crossref_primary_10_1016_j_oraloncology_2014_02_005 crossref_primary_10_1016_j_pvr_2019_03_001 crossref_primary_10_4061_2011_469150 crossref_primary_10_1080_01635580802567158 crossref_primary_10_1016_j_canlet_2007_10_028 crossref_primary_10_1016_j_aorl_2008_12_003 crossref_primary_10_1590_S0034_72992005000400019 crossref_primary_10_1002_hed_21171 crossref_primary_10_1002_jso_23292 crossref_primary_10_1002_jso_25473 crossref_primary_10_4161_cc_23882 crossref_primary_10_1002_ijc_27405 crossref_primary_10_1371_journal_pone_0051690 crossref_primary_10_1002_ijc_29827 crossref_primary_10_1007_s10552_012_0068_x crossref_primary_10_1002_ijc_25479 crossref_primary_10_1371_journal_pone_0050104 crossref_primary_10_1002_jmv_25556 crossref_primary_10_1111_jicd_12313 crossref_primary_10_1002_lary_26772 crossref_primary_10_1007_s10552_011_9791_y crossref_primary_10_1007_s12105_010_0171_9 crossref_primary_10_1016_j_oraloncology_2015_10_020 crossref_primary_10_1002_hed_23369 crossref_primary_10_1002_jso_23067 crossref_primary_10_1097_00008486_200507000_00007 crossref_primary_10_1016_j_oooo_2014_09_004 crossref_primary_10_1002_ijc_28754 crossref_primary_10_1016_j_humpath_2007_08_004 crossref_primary_10_3342_kjorl_hns_2012_55_1_8 crossref_primary_10_1016_j_oraloncology_2007_08_011 crossref_primary_10_1155_2018_6141845 crossref_primary_10_1002_hed_21398 crossref_primary_10_1016_j_amjoto_2011_02_001 crossref_primary_10_1111_j_1600_0528_2008_00450_x crossref_primary_10_1186_s13027_016_0096_3 crossref_primary_10_1136_jcp_2003_007641 crossref_primary_10_3390_cells9020500 crossref_primary_10_1016_j_coms_2018_06_001 crossref_primary_10_1200_JCO_2010_29_2904 crossref_primary_10_1586_14737140_7_5_753 crossref_primary_10_1016_j_ejca_2010_04_016 crossref_primary_10_1007_s00405_017_4615_7 crossref_primary_10_1093_annonc_mdn372 crossref_primary_10_1002_ijc_25015 crossref_primary_10_1016_j_coms_2018_06_007 crossref_primary_10_1016_j_oooo_2012_05_003 crossref_primary_10_1002_ijc_30608 crossref_primary_10_1016_j_jcv_2013_10_028 crossref_primary_10_1186_s12879_014_0737_3 crossref_primary_10_1111_j_1349_7006_2006_00232_x crossref_primary_10_1016_j_arcmed_2007_08_003 crossref_primary_10_1158_0008_5472_CAN_09_4733 crossref_primary_10_1186_1758_3284_4_15 crossref_primary_10_1002_ijc_25023 crossref_primary_10_1186_s13027_015_0007_z crossref_primary_10_1556_030_2022_01794 crossref_primary_10_1002_cncr_29086 crossref_primary_10_1158_1055_9965_EPI_16_0619 crossref_primary_10_1007_s12253_017_0269_4 crossref_primary_10_1097_01_cej_0000236258_80522_fb crossref_primary_10_1186_s13027_020_00310_x crossref_primary_10_1186_1472_6831_11_28 crossref_primary_10_1111_prd_12322 crossref_primary_10_1002_jmv_20583 crossref_primary_10_1007_s10552_010_9564_z crossref_primary_10_1016_j_oraloncology_2015_06_014 crossref_primary_10_1016_j_vaccine_2010_02_098 crossref_primary_10_1158_1078_0432_CCR_13_0152 crossref_primary_10_1093_infdis_jiy160 crossref_primary_10_2217_14750708_5_3_339 crossref_primary_10_1097_01_OLQ_0000118425_49522_2C crossref_primary_10_1371_journal_pone_0182600 crossref_primary_10_1111_j_1600_0714_2005_00329_x crossref_primary_10_4103_jmau_jmau_84_21 crossref_primary_10_1186_s40463_018_0255_1 crossref_primary_10_1016_j_canep_2015_09_013 crossref_primary_10_1093_ije_dyq249 crossref_primary_10_1002_hed_20573 crossref_primary_10_1007_s10147_011_0236_0 crossref_primary_10_1016_j_otc_2013_05_001 crossref_primary_10_1001_jamaoto_2018_0395 crossref_primary_10_12968_denn_2014_10_12_692 crossref_primary_10_4103_jomfp_jomfp_120_21 crossref_primary_10_24011_barofd_1506996 crossref_primary_10_1200_JCO_2014_57_8435 crossref_primary_10_1016_j_ygyno_2006_10_011 crossref_primary_10_1111_j_1600_0714_2012_01183_x crossref_primary_10_1002_cncr_22425 crossref_primary_10_1038_sj_bjc_6603394 crossref_primary_10_3389_fmicb_2019_01439 crossref_primary_10_1016_j_ctro_2016_12_003 crossref_primary_10_1016_j_jcpo_2016_12_006 crossref_primary_10_1016_j_jdermsci_2004_07_005 crossref_primary_10_5507_bp_2010_004 crossref_primary_10_1002_cncr_23764 crossref_primary_10_1186_1743_422X_7_194 crossref_primary_10_1097_CCO_0b013e32836242b4 crossref_primary_10_1016_j_oraloncology_2013_11_004 crossref_primary_10_1128_MMBR_68_2_362_372_2004 crossref_primary_10_1016_j_otorri_2012_02_005 crossref_primary_10_1016_j_amjoto_2010_08_001 crossref_primary_10_1016_j_prp_2008_03_001 crossref_primary_10_1016_j_eimc_2010_10_002 crossref_primary_10_1093_jnci_djh232 crossref_primary_10_1093_jnci_djh233 crossref_primary_10_1158_1055_9965_EPI_14_1217 crossref_primary_10_1051_mbcb_2015011 crossref_primary_10_1016_j_virol_2018_05_022 crossref_primary_10_1038_s41415_019_0318_3 crossref_primary_10_1158_1055_9965_EPI_04_0551 crossref_primary_10_1186_s12879_014_0671_4 crossref_primary_10_1016_j_otohns_2008_11_025 crossref_primary_10_1002_hed_21696 crossref_primary_10_1200_JCO_2011_36_4596 crossref_primary_10_1093_ije_dyp350 crossref_primary_10_1016_j_oraloncology_2006_09_001 crossref_primary_10_1002_jmv_21470 crossref_primary_10_1007_s12032_023_02085_8 crossref_primary_10_1038_sj_onc_1207898 crossref_primary_10_1038_modpathol_2008_180 crossref_primary_10_1002_jmv_24744 crossref_primary_10_1002_lary_21129 crossref_primary_10_1016_j_ijom_2017_09_006 crossref_primary_10_1002_hed_23643 crossref_primary_10_1016_j_oooo_2012_10_017 crossref_primary_10_1002_hed_21220 crossref_primary_10_1111_j_1754_4505_2008_00042_x crossref_primary_10_1080_01635581_2011_570894 crossref_primary_10_3342_kjorl_hns_2010_53_10_620 crossref_primary_10_1007_s10006_008_0131_7 crossref_primary_10_1016_j_oraloncology_2013_12_019 crossref_primary_10_1007_s00520_017_3733_5 crossref_primary_10_1111_ecc_12320 crossref_primary_10_1016_j_diagmicrobio_2011_01_011 crossref_primary_10_1016_j_oraloncology_2013_12_017 crossref_primary_10_1002_ijc_28355 crossref_primary_10_1016_j_bjoms_2010_06_023 crossref_primary_10_3892_ol_2016_5528 crossref_primary_10_1038_sj_bjc_6605778 crossref_primary_10_1016_j_oraloncology_2016_02_014 crossref_primary_10_3390_cancers14174130 crossref_primary_10_1007_s13187_020_01765_7 crossref_primary_10_1002_hed_20108 crossref_primary_10_1517_14728214_2010_497754 crossref_primary_10_1002_ijc_20872 crossref_primary_10_1093_ije_dyp380 crossref_primary_10_1111_odi_13084 crossref_primary_10_1016_j_vaccine_2012_05_070 crossref_primary_10_1002_lio2_37 crossref_primary_10_1002_ijc_21731 crossref_primary_10_1002_ijc_22824 crossref_primary_10_1016_j_oraloncology_2020_104877 crossref_primary_10_1002_ijc_30697 crossref_primary_10_1007_s10555_005_5045_3 crossref_primary_10_1007_s11670_010_0218_1 crossref_primary_10_1108_JHR_07_2018_0062 crossref_primary_10_1002_ijc_26195 crossref_primary_10_1002_mc_21838 crossref_primary_10_2147_JBM_S206027 crossref_primary_10_1007_s00405_017_4828_9 crossref_primary_10_1111_jop_12221 crossref_primary_10_1007_s11912_013_0375_8 crossref_primary_10_1158_0008_5472_CAN_06_0186 crossref_primary_10_1016_j_omton_2024_200926 crossref_primary_10_1007_s00011_016_0985_3 crossref_primary_10_18632_oncotarget_26006 crossref_primary_10_1111_j_1743_7563_2009_01200_x crossref_primary_10_1002_lary_24828 crossref_primary_10_1002_ijc_20664 crossref_primary_10_1007_s11864_009_0113_5 crossref_primary_10_1093_aje_kwn306 crossref_primary_10_1177_0194599811434482 crossref_primary_10_1186_1750_9378_7_13 crossref_primary_10_3389_fphar_2021_753387 crossref_primary_10_1200_JCO_2013_50_3870 crossref_primary_10_1097_OLQ_0b013e31827e87bd crossref_primary_10_1186_s12885_016_2468_x crossref_primary_10_1007_s00105_011_2196_8 crossref_primary_10_1053_j_seminoncol_2008_03_002 crossref_primary_10_1016_j_dnarep_2015_05_003 crossref_primary_10_1007_BF03262210 crossref_primary_10_1093_jnci_djk179 crossref_primary_10_1016_S2084_5308_12_70009_6 crossref_primary_10_1007_s10552_018_1090_4 crossref_primary_10_1016_j_oraloncology_2010_07_010 crossref_primary_10_1002_ijc_33514 crossref_primary_10_1111_cas_12106 crossref_primary_10_1007_s13277_010_0135_4 crossref_primary_10_1016_j_otc_2013_08_009 crossref_primary_10_1002_jmv_28254 crossref_primary_10_1016_j_oraloncology_2007_02_005 crossref_primary_10_1002_ijc_24807 crossref_primary_10_1177_0022034509333371 crossref_primary_10_4103_jpbs_jpbs_713_24 crossref_primary_10_56373_2006_2_4 crossref_primary_10_1016_j_virol_2007_05_030 crossref_primary_10_1093_jnci_djh074 crossref_primary_10_3342_kjorl_hns_2014_57_3_143 crossref_primary_10_1097_CEJ_0000000000000179 crossref_primary_10_18632_oncotarget_28232 crossref_primary_10_1128_JVI_00538_08 crossref_primary_10_1002_cncr_30955 crossref_primary_10_1111_j_1749_4486_2011_02361_x crossref_primary_10_1111_odi_12365 crossref_primary_10_1002_ijc_22633 crossref_primary_10_1038_bjc_2015_99 crossref_primary_10_1016_j_jcv_2011_11_005 crossref_primary_10_1007_s11195_014_9347_7 crossref_primary_10_3892_ijo_2015_2990 crossref_primary_10_1016_j_ijrobp_2010_11_059 crossref_primary_10_11124_JBISRIR_2016_003061 crossref_primary_10_1016_S1634_6939_10_51561_8 crossref_primary_10_1093_infdis_jiae345 crossref_primary_10_1016_j_canep_2021_102020 crossref_primary_10_1007_s10269_015_2522_3 crossref_primary_10_1016_j_otc_2005_11_012 crossref_primary_10_1007_s00705_007_0022_5 crossref_primary_10_3923_ijcr_2011_222_232 crossref_primary_10_1111_odi_12135 crossref_primary_10_1038_modpathol_3800979 crossref_primary_10_1016_j_joms_2008_05_175 crossref_primary_10_1002_hed_23803 crossref_primary_10_1016_j_oraloncology_2013_10_009 crossref_primary_10_1111_j_1600_0714_2009_00799_x crossref_primary_10_3390_ijerph19084802 crossref_primary_10_1002_ijc_28194 crossref_primary_10_1111_jop_12686 crossref_primary_10_1038_bmt_2015_63 crossref_primary_10_1097_MD_0000000000017800 crossref_primary_10_1016_j_archoralbio_2015_11_017 crossref_primary_10_1016_j_joms_2013_02_019 crossref_primary_10_1016_j_mehy_2007_07_043 crossref_primary_10_1016_S0140_6736_04_16194_1 crossref_primary_10_1111_j_1365_2559_2010_03727_x crossref_primary_10_1016_j_ypmed_2004_09_030 crossref_primary_10_1016_j_otoeng_2012_07_013 crossref_primary_10_1016_j_semcancer_2019_09_011 crossref_primary_10_1007_s00060_022_7734_8 crossref_primary_10_1007_s10508_009_9578_3 crossref_primary_10_1007_s10147_013_0660_4 crossref_primary_10_1371_journal_pone_0068329 crossref_primary_10_1002_cncr_26423 crossref_primary_10_1016_j_jes_2025_01_022 crossref_primary_10_1007_s10597_009_9280_x crossref_primary_10_1002_rmv_471 crossref_primary_10_1093_jnci_djv128 crossref_primary_10_1002_ijc_21577 crossref_primary_10_1177_1066896910382005 crossref_primary_10_1053_j_semdp_2014_12_003 crossref_primary_10_1002_ijc_29063 crossref_primary_10_1016_S1773_035X_11_71056_5 crossref_primary_10_1016_S1808_8694_15_31208_8 crossref_primary_10_1002_cncr_24184 crossref_primary_10_3389_fgene_2020_00986 crossref_primary_10_1073_pnas_0606698103 crossref_primary_10_1093_jnci_djn011 crossref_primary_10_1186_s13027_018_0205_6 crossref_primary_10_1038_sj_bjc_6606091 crossref_primary_10_1007_s12032_011_0143_2 crossref_primary_10_1002_path_2227 crossref_primary_10_1093_jnci_djn025 crossref_primary_10_1007_s11912_005_0041_x crossref_primary_10_1016_j_soc_2015_03_001 crossref_primary_10_1111_jop_12291 crossref_primary_10_3390_v15020451 crossref_primary_10_1111_j_1601_0825_2012_01947_x crossref_primary_10_1136_jcp_2010_078154 crossref_primary_10_1002_lary_20509 crossref_primary_10_1007_s10006_024_01253_y crossref_primary_10_1111_j_1601_0825_2005_01112_x crossref_primary_10_1016_S1632_3475_16_76086_3 crossref_primary_10_4061_2011_806345 crossref_primary_10_1097_MD_0000000000004228 crossref_primary_10_1016_j_canlet_2009_06_026 crossref_primary_10_1002_ijc_31167 crossref_primary_10_1177_0009922806289907 crossref_primary_10_1590_1414_431x20187810 crossref_primary_10_4161_hv_34303 crossref_primary_10_1186_1477_5956_7_29 crossref_primary_10_1002_cncr_28532 crossref_primary_10_1007_s00430_020_00697_9 crossref_primary_10_1016_j_meegid_2012_05_004 crossref_primary_10_1128_JCM_43_11_5526_5535_2005 crossref_primary_10_3310_hta19910 crossref_primary_10_3390_diagnostics13122096 crossref_primary_10_1155_2015_829349 crossref_primary_10_1016_j_prosdent_2015_10_022 crossref_primary_10_1053_j_seminoncol_2009_07_005 crossref_primary_10_1111_j_1600_0714_2010_00910_x crossref_primary_10_1016_j_oraloncology_2021_105397 crossref_primary_10_1016_j_ogc_2007_09_007 crossref_primary_10_14260_jemds_2020_171 crossref_primary_10_1016_j_canep_2019_101615 crossref_primary_10_1093_aje_kwp222 crossref_primary_10_1016_j_oooo_2021_08_023 crossref_primary_10_1177_0022034511399914 crossref_primary_10_1016_j_oraloncology_2016_12_015 crossref_primary_10_1038_nrc1549 crossref_primary_10_1111_j_1600_0714_2008_00670_x crossref_primary_10_3389_fcimb_2020_537650 crossref_primary_10_1016_j_ygyno_2011_02_018 crossref_primary_10_1200_JCO_20_03128 crossref_primary_10_1200_JCO_2012_47_2738 crossref_primary_10_1111_j_1365_2559_2005_02276_x crossref_primary_10_1111_j_1600_0714_2011_01062_x crossref_primary_10_1111_jop_12023 crossref_primary_10_1016_j_yexmp_2015_06_018 crossref_primary_10_1111_his_13260 crossref_primary_10_1158_1055_9965_EPI_11_0734 crossref_primary_10_1007_s11912_006_0048_y crossref_primary_10_1200_JCO_2005_04_6136 crossref_primary_10_3390_cancers12071904 crossref_primary_10_1016_j_oraloncology_2010_02_015 crossref_primary_10_1002_hed_23087 crossref_primary_10_1111_j_1600_0714_2005_00365_x crossref_primary_10_18231_j_ijpo_2021_098 crossref_primary_10_1093_ije_dyu255 crossref_primary_10_1002_hed_26116 crossref_primary_10_3748_wjg_v24_i43_4928 crossref_primary_10_1111_eos_12007 crossref_primary_10_1158_1055_9965_EPI_08_0054 crossref_primary_10_1111_nyas_14509 crossref_primary_10_1002_jmv_26130 crossref_primary_10_1016_j_ypmed_2011_08_017 crossref_primary_10_1007_s00432_009_0648_7 crossref_primary_10_1177_0022034509333446 crossref_primary_10_3390_v7072802 crossref_primary_10_3390_cancers16213658 crossref_primary_10_1080_15546128_2012_707084 crossref_primary_10_1016_j_vaccine_2014_03_033 crossref_primary_10_4137_CMENT_S5129 crossref_primary_10_1007_s00405_007_0546_z crossref_primary_10_1097_MAJ_0b013e3182574831 crossref_primary_10_1158_1055_9965_EPI_06_0636 crossref_primary_10_1016_j_oraloncology_2007_01_018 crossref_primary_10_18632_oncotarget_20004 crossref_primary_10_1002_ijc_22262 crossref_primary_10_4065_83_4_489 crossref_primary_10_1016_j_sste_2010_03_005 crossref_primary_10_1002_hed_26330 crossref_primary_10_1002_14651858_CD010341_pub2 crossref_primary_10_1016_j_jormas_2017_02_004 crossref_primary_10_4081_jphr_2014_157 crossref_primary_10_1016_j_ejca_2010_06_125 crossref_primary_10_1158_1055_9965_EPI_10_0506 crossref_primary_10_1016_j_jormas_2017_02_003 crossref_primary_10_7314_APJCP_2015_16_4_1371 crossref_primary_10_1080_00016480701558880 crossref_primary_10_1200_JCO_2016_69_1642 crossref_primary_10_1590_S1415_790X2011000100009 crossref_primary_10_1136_bmjopen_2020_039383 crossref_primary_10_3390_ijms25158038 crossref_primary_10_7314_APJCP_2014_15_19_8351 crossref_primary_10_1111_nyas_14328 crossref_primary_10_1158_1055_9965_EPI_14_1416 crossref_primary_10_1186_s12885_018_4247_3 crossref_primary_10_1158_1078_0432_CCR_14_3323 crossref_primary_10_1002_cncr_32412 crossref_primary_10_1093_ije_dyw069 crossref_primary_10_1016_j_joms_2006_11_011 crossref_primary_10_1016_j_clon_2010_05_024 crossref_primary_10_51847_wXhwcY0KXx crossref_primary_10_1111_ecc_12110 crossref_primary_10_1007_BF03256442 crossref_primary_10_1016_j_ijom_2008_09_004 crossref_primary_10_1016_j_bjoms_2014_05_010 crossref_primary_10_1099_jgv_0_001069 crossref_primary_10_1002_wnan_1830 crossref_primary_10_14219_jada_archive_2011_0298 crossref_primary_10_14219_jada_archive_2011_0297 crossref_primary_10_18632_oncotarget_22682 crossref_primary_10_1016_j_oraloncology_2005_11_007 crossref_primary_10_1056_NEJMe078004 crossref_primary_10_1186_s12916_022_02233_3 crossref_primary_10_1002_hed_23443 crossref_primary_10_3390_cancers16172957 crossref_primary_10_1007_s12032_017_0912_7 crossref_primary_10_1016_j_otc_2013_04_008 crossref_primary_10_1590_1414_431X20132703 crossref_primary_10_4161_hv_24337 crossref_primary_10_1186_s13027_018_0175_8 crossref_primary_10_1016_j_oraloncology_2011_12_013 crossref_primary_10_1186_s41199_018_0031_y crossref_primary_10_3389_fonc_2022_926555 crossref_primary_10_1177_0956462413481527 crossref_primary_10_1177_154405910708600202 crossref_primary_10_2334_josnusd_15_0629 crossref_primary_10_1097_01_tp_0000231706_79165_e5 crossref_primary_10_1177_0897190013488801 crossref_primary_10_1038_srep06592 crossref_primary_10_5935_1808_8694_20130065 crossref_primary_10_1002_cam4_3944 crossref_primary_10_1016_j_oraloncology_2008_08_001 crossref_primary_10_1016_j_tvr_2024_200297 crossref_primary_10_1016_j_coviro_2021_09_013 crossref_primary_10_1007_s10552_011_9792_x crossref_primary_10_1038_s41416_020_01031_z crossref_primary_10_1016_j_oraloncology_2017_05_010 crossref_primary_10_1111_odi_15062 crossref_primary_10_1016_j_oraloncology_2015_04_011 crossref_primary_10_1001_jamaoto_2024_0262 crossref_primary_10_1016_j_ijom_2015_04_015 crossref_primary_10_1186_1750_9378_2_21 crossref_primary_10_1002_cncr_23735 crossref_primary_10_1002_lary_24243 crossref_primary_10_1111_1753_6405_12352 crossref_primary_10_1016_S1808_8694_15_30068_9 crossref_primary_10_1002_cncr_23976 crossref_primary_10_1007_s12105_010_0161_y crossref_primary_10_1016_j_ygyno_2013_02_015 crossref_primary_10_1308_003588414X14055925061676 crossref_primary_10_1111_j_1601_0825_2012_01956_x crossref_primary_10_1016_j_oraloncology_2012_07_002 crossref_primary_10_1016_j_oraloncology_2017_07_006 crossref_primary_10_1016_j_vaccine_2006_05_120 crossref_primary_10_1186_1758_3284_2_6 crossref_primary_10_12998_wjcc_v2_i6_172 crossref_primary_10_1042_BSR20202083 crossref_primary_10_1002_cncr_23745 crossref_primary_10_1016_j_oraloncology_2016_11_003 crossref_primary_10_1016_j_vaccine_2006_05_115 crossref_primary_10_1111_ans_13607 crossref_primary_10_1002_cncr_29039 crossref_primary_10_1002_lio2_877 crossref_primary_10_1007_s00705_006_0829_5 crossref_primary_10_1016_j_vaccine_2006_05_111 crossref_primary_10_1002_cncr_31359 crossref_primary_10_1002_hed_23486 crossref_primary_10_1016_j_canep_2015_08_010 crossref_primary_10_1016_j_currproblcancer_2017_02_006 crossref_primary_10_1099_vir_0_010637_0 crossref_primary_10_1155_2012_571862 crossref_primary_10_1007_s00405_009_1109_2 crossref_primary_10_1586_14760584_2015_964213 crossref_primary_10_1074_mcp_RA119_001530 crossref_primary_10_1007_s00432_007_0219_8 crossref_primary_10_1002_hed_25630 crossref_primary_10_1016_j_wneu_2018_10_018 crossref_primary_10_1002_cncr_30251 crossref_primary_10_1016_j_jasc_2017_02_002 crossref_primary_10_1016_j_oor_2024_100443 crossref_primary_10_1111_j_1601_0825_2011_01792_x crossref_primary_10_18632_oncotarget_23116 crossref_primary_10_1002_ijc_28888 crossref_primary_10_1097_01_inf_0000245094_15643_8c crossref_primary_10_1002_gcc_22099 crossref_primary_10_1016_j_virol_2005_04_002 crossref_primary_10_1053_j_seminoncol_2004_09_011 crossref_primary_10_1158_1055_9965_EPI_12_0662 crossref_primary_10_1111_j_1600_0528_2007_00332_x crossref_primary_10_35420_jcohns_2012_23_1_3 crossref_primary_10_1002_rmv_1822 crossref_primary_10_1007_s41548_018_0010_3 crossref_primary_10_3390_ijms25020798 crossref_primary_10_1186_1743_422X_10_334 |
| ContentType | Journal Article |
| Copyright | 2004 INIST-CNRS Copyright Oxford University Press(England) Dec 3, 2003 |
| Copyright_xml | – notice: 2004 INIST-CNRS – notice: Copyright Oxford University Press(England) Dec 3, 2003 |
| CorporateAuthor | IARC Multicenter Oral Cancer Study Group |
| CorporateAuthor_xml | – name: IARC Multicenter Oral Cancer Study Group |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7TO 7U7 7U9 C1K H94 K9. NAPCQ 7X8 |
| DOI | 10.1093/jnci/djg107 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Oncogenes and Growth Factors Abstracts Toxicology Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Toxicology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Nursing & Allied Health Premium MEDLINE Oncogenes and Growth Factors Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1460-2105 |
| EndPage | 1783 |
| ExternalDocumentID | 545981911 14652239 15927572 10_1093_jnci_djg107 |
| Genre | Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
| GeographicLocations | Central America Europe Africa West Indies Sudan United Kingdom Northern Ireland North America Oceania Spain India Canada Cuba Asia America Poland Italy Australia |
| GroupedDBID | --- -E4 -~X .2P .55 .GJ .I3 .XZ .ZR 08P 0R~ 1TH 29L 2QL 2WC 354 3O- 4.4 482 48X 53G 5GY 5RE 5VS 5WD 70D 96U AABZA AACZT AAHTB AAJKP AAJQQ AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAWTL AAYXX ABCQX ABDFA ABEFU ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABNGD ABNHQ ABNKS ABOCM ABPEJ ABPMR ABPPZ ABPTD ABQLI ABQNK ABVGC ABXVV ABZBJ ACBMB ACGFO ACGFS ACGOD ACKOT ACNCT ACPRK ACUFI ACUKT ACUTO ACYHN ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADRTK ADVEK ADXHL ADYVW AEGPL AEJOX AEKSI AEMDU AEMQT AENZO AEPUE AETBJ AEWNT AFAZI AFCHL AFFNX AFFZL AFIYH AFOFC AFRAH AFXAL AFYAG AGINJ AGKEF AGORE AGQPQ AGSYK AGUTN AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN ASPBG ATGXG AVWKF AZFZN BAWUL BAYMD BCRHZ BEYMZ BKOMP BTRTY BVRKM C45 CAG CDBKE CITATION COF CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBS EE~ EJD EMOBN ENERS F5P F8P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GOZPB GRPMH GX1 H5~ HAR HVGLF HW0 HZ~ IH2 IOX J21 J5H JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B LXL LXN LXY M-Z MHKGH ML0 N9A NGC NOMLY NOYVH NTWIH NVLIB O0~ OAUYM OAWHX OBH OCB OCZFY ODMLO ODZKP OGEVE OHH OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PB- PEELM PQQKQ Q.- Q1. Q5Y R44 RD5 RNI RNS ROL ROX ROZ RUSNO RW1 RXO RZF RZO TCURE TEORI TJX TMA TR2 TWZ UDS UPT VVN W8F WH7 WOQ X7H X7M YAYTL YHZ YKOAZ YQT YXANX ZKX ZRR ZY1 ~91 ~H1 ~X8 -DD 186 8WZ A6W AAGKA AAKAS AAPGJ AAQQT AAWDT ABQTQ ABSMQ ACFRR ACPQN ACUTJ ACVCV ACZBC ADMTO ADZCM AEHUL AEKPW AETEA AFFQV AFSHK AGKRT AGMDO AGNAY AI. AJDVS APJGH AQDSO AQKUS ATTQO AVNTJ BZKNY EIHJH FA8 H13 IQODW M49 MBLQV MVM NU- OBFPC O~Y QBD VH1 XJT Y6R YR5 ADJQC ADRIX ADZXQ CGR CUY CVF ECM EIF NPM RHF VXZ 7TO 7U7 7U9 C1K H94 K9. NAPCQ 7X8 |
| ID | FETCH-LOGICAL-c3917-f793040b6bb5008c59a746ddc05e8bb82c44834b9dae85a4ac38269dbaac1fbc3 |
| ISSN | 1460-2105 0027-8874 |
| IngestDate | Sun Sep 28 01:40:47 EDT 2025 Sat Sep 27 19:10:34 EDT 2025 Mon Jun 30 11:05:58 EDT 2025 Wed Feb 19 02:33:06 EST 2025 Wed Apr 02 07:26:35 EDT 2025 Thu Apr 24 23:04:30 EDT 2025 Tue Jul 01 03:24:23 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 23 |
| Keywords | Human Oral cancer Stomatology Multicenter study Papovaviridae Malignant tumor Case control study Carcinogenesis Epidemiology Infection Papillomavirus Virus Human papillomavirus Cancerology Viral disease Risk factor Oral cavity disease Public health |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c3917-f793040b6bb5008c59a746ddc05e8bb82c44834b9dae85a4ac38269dbaac1fbc3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| OpenAccessLink | https://academic.oup.com/jnci/article-pdf/95/23/1772/10892686/zv802303001772.pdf |
| PMID | 14652239 |
| PQID | 220981788 |
| PQPubID | 41605 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_71428529 proquest_miscellaneous_19218254 proquest_journals_220981788 pubmed_primary_14652239 pascalfrancis_primary_15927572 crossref_citationtrail_10_1093_jnci_djg107 crossref_primary_10_1093_jnci_djg107 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2003-12-03 |
| PublicationDateYYYYMMDD | 2003-12-03 |
| PublicationDate_xml | – month: 12 year: 2003 text: 2003-12-03 day: 03 |
| PublicationDecade | 2000 |
| PublicationPlace | Cary, NC |
| PublicationPlace_xml | – name: Cary, NC – name: United States – name: Oxford |
| PublicationTitle | JNCI : Journal of the National Cancer Institute |
| PublicationTitleAlternate | J Natl Cancer Inst |
| PublicationYear | 2003 |
| Publisher | Oxford University Press Oxford Publishing Limited (England) |
| Publisher_xml | – name: Oxford University Press – name: Oxford Publishing Limited (England) |
| SSID | ssj0000924 |
| Score | 2.3987114 |
| Snippet | Human papillomavirus (HPV), the causal agent of cervical cancer, appears to be involved in the etiology of cancer of the oral cavity and oropharynx. To... BACKGROUND: Human papillomavirus (HPV), the causal agent of cervical cancer, appears to be involved in the etiology of cancer of the oral cavity and... |
| SourceID | proquest pubmed pascalfrancis crossref |
| SourceType | Aggregation Database Index Database Enrichment Source |
| StartPage | 1772 |
| SubjectTerms | Adult Aged Antibodies, Viral - blood Biological and medical sciences Cancer Case-Control Studies DNA, Viral - isolation & purification Enzyme-Linked Immunosorbent Assay Female Human papillomavirus Humans International Cooperation Life Style Male Medical research Medical sciences Middle Aged Mouth Odds Ratio Oropharyngeal Neoplasms - virology Otorhinolaryngology. Stomatology Papillomaviridae - genetics Papillomaviridae - immunology Papillomaviridae - isolation & purification Papillomavirus Infections - complications Papillomavirus Infections - virology Polymerase Chain Reaction Risk Assessment Risk Factors Seroepidemiologic Studies Sexual Behavior Smoking - adverse effects Throat Tropical medicine Tumor Virus Infections - complications Tumor Virus Infections - virology Tumors Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology Viruses |
| Title | Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/14652239 https://www.proquest.com/docview/220981788 https://www.proquest.com/docview/19218254 https://www.proquest.com/docview/71428529 |
| Volume | 95 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3battAEF3cFEohlF4TN226D3kqqLG1um3fgklI2sSFYoPfxO5qZZK6krHsBvob_eHOaCTLah16eRFCXo-NztFqdvbMDGNHQhjtCu07PWMiLKodOjKwcKY8LYzUXt_iQvFqGJyPvQ8Tf9Lp_NhQLa2W-p35vjWv5H9QhWuAK2bJ_gOya6NwAc4BXzgCwnD8K4wpAj9X8-vZLP-qvl0vVlRyuUy7NwjoohZutEN_J5RyiRrDWnuH2waD8iukMkTZJpZ6XtefrV3Y4eCiDCRs-LKlUrK2XRlZyxCacOtiYSmt5nOOgsq82QApMJmlUNMVbdzjmInCV3azxXWL5cR_VfqjlAiok98WX0j0i4aXqhXLEKUuRGxMv17Qc2ARSvvcdsu1as6mxpwVN12xMQP3Q2oF9Nurgcpm3WQGYU1uplW33XYJ7uGn-Gx8eRmPTieje-y-G4JDhp72xcfm9S6pU3L9t6qkTzB_jMaPyXTLzdmdqwKeuJRapdy9lil9mtFj9qgCkJ8Qs56wjs2esgdXldziGZuWBONtgnFAjiPBOBHsPQf0eYtenOjFgV68phfPM07M4Bv04iW9nrPx2elocO5UnTkcI2B976Qwq8PsrwOtfXAijS9V6AVJYnq-jbSOXONhkFrLRNnIV54yApaxMtFKmX6qjXjBdrI8s_uMK5VGfhKmNk0SL8UAG_jcSroRuuLWBl32tr6RsanK1mP3lFlM8gkR412P6a532dF68JyqtWwfdthCpBnrSzf0Q7fLDmqI4up5L2LX7cmoH0ZRl71ZfwqTMe6wqczmqyLG4oIYcrl7RIgVDn1XdtkeId_8thfAWkjIl3_87gF72Dw8r9jOcrGyr8E1XurDkqo_AfZHwTQ |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+papillomavirus+and+oral+cancer%3A+the+International+Agency+for+Research+on+Cancer+multicenter+study&rft.jtitle=JNCI+%3A+Journal+of+the+National+Cancer+Institute&rft.au=Herrero%2C+Rolando&rft.au=Castellsagu%C3%A9%2C+Xavier&rft.au=Pawlita%2C+Michael&rft.au=Lissowska%2C+Jolanta&rft.date=2003-12-03&rft.issn=1460-2105&rft.eissn=1460-2105&rft.volume=95&rft.issue=23&rft.spage=1772&rft_id=info:doi/10.1093%2Fjnci%2Fdjg107&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2105&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2105&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2105&client=summon |